HYDERABAD: Bharat Biotech, which is developing India’s first indigenous Covid-19 vaccine, Covaxin, expects critical Phase III trials to be completed after April 2021. Only after that will the company apply for the commercial license and WHO prequalification, a senior company official said. However, Covaxin could be available for emergency use …
Read More »Signature: Covaxin tests until April, emergency use possible sooner | India News
